Getinge AB Swedish stock analysis

Getinge is a global medical technology company founded in Sweden a long time ago, back in 1904. The firm provides equipment and systems within healthcare and life sciences. The Swedish healthcare company has lost more than 50% of its value since the end of November 2021. After such a strong sell-off, a new bullish leg is expected. And that’s exactly what has happened on Getinge AB Swedish stock.

There is a new weekly demand imbalance created at 192 SEK where we can start thinking of buying shares of Getinge AB stock. As of December 2022, the stock ranges between two strong imbalances sitting at 192 and 281, respectively. Taking action right now is not a good idea. We must wait.

Getinge AB Swedish stock price today

As supply and demand traders, we do not need to pay attention to fundamental analysis. Unless you are doing very short-term trading and scalping, you should not worry about fundamentals for stocks and ETFs.

Trading is just waiting for the right trigger points and scenarios to present themselves, this game has a name, and it’s called the waiting game. We must patiently wait for the correct scenarios and setups to happen and for the price to pull back or dip into the price levels we want to trade. These price levels are made of supply and demand imbalances in our case. You can use these imbalances to plan your trades in lower timeframes.

Join our supply and demand online trading academy If you want to learn how to trade stocks using our supply and demand trading strategy.